Contemporary molecular prognostic signatures in glioma
Release Date: 08/30/2024
Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas
Neuro-Oncology: The Podcast
Dr. Iyad Alnahhas interviews Drs. David Schiff and Ranjit Bindra about their recent manuscript entitled “Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant Gliomas”, published online in Neuro-Oncology in October 2025.
info_outline
Introduction to Neuro-Oncology: The Podcast 2.0
Neuro-Oncology: The Podcast
In this episode, Dr. Evan Noch and Dr. Maya Graham discuss the exciting new podcast subtypes and the episodes to come.
info_outline
Radiotherapy induced neurocognitive decline
Neuro-Oncology: The Podcast
Description: Dr. Iyad Alnahhas interviews Dr. Charlotte Sleurs about her and her team's recent manuscript entitled: "Radiotherapy-induced neurocognitive decline among adult intracranial tumor patients: A voxel-based approach", published online in Neuro-Oncology in May 2025.
info_outline
QOL and cognitive functioning in patients with oligodendroglioma
Neuro-Oncology: The Podcast
Dr. Iyad Alnahhas interviews Drs. Florien Boele and Martin Klein about their recent manuscript entitled: “Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation”, published online in Neuro-Oncology in July 2025.
info_outline
Post-operative radiation in recurrent grade 1 meningiomas
Neuro-Oncology: The Podcast
Dr. Iyad Alnahhas interviews Drs. Felix Sahm and Maximilian Deng about their recent manuscript entitled: "Postoperative radiotherapy in subtotally-resected recurrent WHO grade 1 meningiomas with intermediate/ high-risk molecular profiles", published online in Neuro-Oncology in May 2025.
info_outline
mRNA CAR T against GD2 in high-grade glioma models
Neuro-Oncology: The Podcast
Dr. Maya Graham interviews Dr. Jessica Foster about her and her team's recent manuscript, entitled "Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high-grade glioma models". This work was published online in Neuro-Oncology in May 2025.
info_outline
A transcriptomic atlas of CNS tumors
Neuro-Oncology: The Podcast
Dr. Evan Noch interviews Dr. Akshitkumar Mistry about his and his team's recent manuscript entitled "A clinically annotated transcriptomic atlas of nervous system tumors", published online in Neuro-Oncology in May 2025 Link to the paper:
info_outline
Gut microbiome in primary CNS lymphoma
Neuro-Oncology: The Podcast
Dr. Iyad Alnahhas interviews Drs. Isaias Hernandez-Verdin and Agusti Alentorn about their recent manuscript entitled: "Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: An ancillary study from the BLOCAGE trial", published online in Neuro-Oncology in March 2025 Link:
info_outline
Germline analysis of diffuse midline glioma
Neuro-Oncology: The Podcast
Dr. Evan Noch interviews Dr. Marion Mateos about her and her team's recent manuscript entitled: "Germline analysis of an international cohort of pediatric diffuse midline glioma patients", published online in Neuro-Oncology in March 2025.
info_outline
The proteomic landscape of diffuse midline glioma
Neuro-Oncology: The Podcast
Dr. Iyad Alnahhas interviews Drs. Cynthia Hawkins and Arun Vadivel about their recent manuscript entitled: "The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases", published online in Neuro-Oncology in February 2025.
info_outlineDr. Iyad Alnahhas interviews Dr. Linda Bi, Hia Ghosh and Ruchit Patel about their recent manuscript entitled: "Contemporary Prognostic Signatures and Refined Risk Stratification of Gliomas: An Analysis of 4400 Tumors", published online in Neuro-Oncology in August 2024.
More Information:
https://academic.oup.com/